Europe Diagnostic Specialty Antibodies Market 2020-2027 by Type (Monoclonal, Polyclonal, Others), Application (Oncology, Hepatitis, Infectious, Dengue), End User (Hospitals, Diagnostic Labs), and Country: Trend Outlook and Growth Opportunity
Europe Diagnostic Specialty Antibodies Market 2020-2027 by Type (Monoclonal, Polyclonal, Others), Application (Oncology, Hepatitis, Infectious, Dengue), End User (Hospitals, Diagnostic Labs), and Country: Trend Outlook and Growth Opportunity
Europe Diagnostic Market by End User (Office Building Construction, Retail Construction, Hospitality Construction, Institutional Construction, Other End Users), by North America (United States, Canada, Mexico), by South America (Brazil, Argentina, Rest of South America), by Europe (United Kingdom, Germany, France, Italy, Spain, Russia, Benelux, Nordics, Rest of Europe), by Middle East & Africa (Turkey, Israel, GCC, North Africa, South Africa, Rest of Middle East & Africa), by Asia Pacific (China, India, Japan, South Korea, ASEAN, Oceania, Rest of Asia Pacific) Forecast - is a comprehensive report that provides insights into the market dynamics, including the key drivers, challenges, and opportunities shaping the industry landscape. It also delves into the competitive landscape, highlighting the major players and their strategies.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Europe diagnostic specialty antibodies market accounted for $5,432.3 million in 2020 and will grow by 4.5% annually over 2020-2027 owing to the high number of patient pool undergoing diagnosis of HIV and growing demand for speciality diagnostics around the world, the advancements in DNA based technologies and diagnostics, and the increase in the prevalence of diseases such as infectious diseases, influenza and cancer.
Highlighted with 30 tables and 38 figures, this 91-page report “Europe Diagnostic Specialty Antibodies Market 2020-2027 by Type (Monoclonal, Polyclonal, Others), Application (Oncology, Hepatitis, Infectious, Dengue), End User (Hospitals, Diagnostic Labs), and Country: Trend Outlook and Growth Opportunity” is based on a comprehensive research of the entire Europe diagnostic specialty antibodies market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2027 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe diagnostic specialty antibodies market in every aspect of the classification from perspectives of Type, Application, End User, and Country.
Based on Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section.
• Monoclonal Antibodies
• Polyclonal Antibodies
• Other Types
Based on Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section.
• Natural/Biological Products
• Synthetic Products
Based on Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section.
• Oncology Diagnosis
• Hepatitis Diagnosis
• Infectious Disease Diagnosis
• Dengue Diagnostics
• Tuberculosis Diagnostics
• HIV Diagnostics
• Other Applications
Based on End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section.
• Hospitals & Clinics
• Diagnostic Laboratories
• Other End Users
Geographically, the following national/local markets are fully investigated:
• Germany
• UK
• France
• Spain
• Italy
• Russia
• Rest of Europe (further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2017-2027. The breakdown of key national markets by Type, Application, and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Key Players (this may not be a complete list and extra companies can be added upon request):
Abbott Laboratories
Abcam plc
Agilent Technologies, Inc.
Aytu BioScience, Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Boehringer Ingelheim International GmbH
Creative Diagnostics
Enzo Life Sciences, Inc.
F. Hoffmann-La Roche AG
Merck KGaA
Polymun Scientific Immunbiologische Forschung GmbH
Sanofi S.A.
Sartorius AG
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 5
1.1 Industry Definition and Research Scope 5
1.1.1 Industry Definition 5
1.1.2 Research Scope 6
1.2 Research Methodology 9
1.2.1 Overview of Market Research Methodology 9
1.2.2 Market Assumption 10
1.2.3 Secondary Data 10
1.2.4 Primary Data 10
1.2.5 Data Filtration and Model Design 11
1.2.6 Market Size/Share Estimation 12
1.2.7 Research Limitations 13
1.3 Executive Summary 14
2 Market Overview and Dynamics 16
2.1 Market Size and Forecast 16
2.1.1 Impact of COVID-19 on World Economy 17
2.1.2 Impact of COVID-19 on the Market 19
2.2 Major Growth Drivers 21
2.3 Market Restraints and Challenges 24
2.4 Emerging Opportunities and Market Trends 27
2.5 Porter’s Fiver Forces Analysis 31
3 Segmentation of Europe Market by Type 35
3.1 Market Overview by Type 35
3.2 Monoclonal Antibodies 37
3.3 Polyclonal Antibodies 38
3.4 Other Types 39
4 Segmentation of Europe Market by Application 40
4.1 Market Overview by Application 40
4.2 Oncology Diagnosis 42
4.3 Hepatitis Diagnosis 43
4.4 Infectious Disease Diagnosis 44
4.5 Dengue Diagnostics 45
4.6 Tuberculosis Diagnostics 46
4.7 HIV Diagnostics 47
4.8 Other Applications 48
5 Segmentation of Europe Market by End User 49
5.1 Market Overview by End User 49
5.2 Hospitals & Clinics 51
5.3 Diagnostic Laboratories 52
5.4 Other End Users 53
6 European Market 2020-2027 by Country 54
6.1 Overview of European Market 54
6.2 UK 57
6.3 France 59
6.4 Germany 61
6.5 Spain 63
6.6 Italy 65
6.7 Russia 67
6.8 Rest of European Market 69
7 Competitive Landscape 71
7.1 Overview of Key Vendors 71
7.2 New Product Launch, Partnership, Investment, and M&A 74
7.3 Company Profiles 75
Abbott Laboratories 75
Abcam plc 77
Agilent Technologies, Inc. 78
Aytu BioScience, Inc. 79
Becton, Dickinson and Company 80
Bio-Rad Laboratories, Inc. 81
Boehringer Ingelheim International GmbH 82
Creative Diagnostics 83
Enzo Life Sciences, Inc. 84
F. Hoffmann-La Roche AG 85
Merck KGaA 86
Polymun Scientific Immunbiologische Forschung GmbH 87
Sanofi S.A. 88
Sartorius AG 89
Thermo Fisher Scientific Inc. 90
RELATED REPORTS 91
Research Methodology:
Europe Diagnostic Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|